Agios Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 9,487,500 shares of common stock of…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Davis Polk Advises Centogene N.V. on Its Initial Public Offering
Davis Polk advised Centogene N.V. on its $56 million initial public offering of 4,000,000 of its common shares. In addition, Centogene has granted the underwriters a 30-day option to…
Davis Polk Advises Clarivate Analytics plc on Its $1.850 Billion Refinancing
Davis Polk advised Clarivate Analytics plc in connection with the refinancing of its existing credit facility and unsecured senior notes pursuant to which its indirect wholly owned…
Davis Polk Advises Hudson Group on Its Acquisition of a Controlling Stake in the Assets of OHM Concession Group
Davis Polk is advising Hudson Group in connection with its acquisition of a controlling stake in the assets of OHM Concession Group LLC. The addition of OHM adds notable food and beverage…
Progyny $149.5 Million Initial Public Offering and Nasdaq Listing
Davis Polk advised the underwriters on the SEC-registered initial public offering by Progyny, Inc. of 11,500,000 common shares, consisting of 6,700,000 shares sold by Progyny and 4,800,000…
Davis Polk Advises BRP Group, Inc. on Its $229.6 Million Initial Public Offering
Davis Polk advised BRP Group, Inc. on its $229.6 million initial public offering of 16,400,000 shares of Class A common stock. The shares of Class A common stock are listed on the Nasdaq…
Davis Polk Advises Charles River Laboratories International, Inc. on Its $500 Million Notes Offering
Davis Polk advised Charles River Laboratories International, Inc. in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of 4.250% senior notes…
Innate Pharma $79 Million U.S. Initial Public Offering of ADS on Nasdaq and Concurrent Private Placement
Davis Polk advised the underwriters in connection with an initial public offering of 8,047,227 American Depositary Shares of Innate Pharma S.A. and a concurrent private placement of 4,452…
Davis Polk Advises Hudson Group on Its Acquisition of Brookstone Airport Stores from Apex Digital
Davis Polk is advising Hudson Group in connection with its acquisition of assets related to the operation of Brookstone stores in U.S. airports from Apex Digital, Inc. Hudson has also…
Davis Polk Advises SS&C on Its Acquisition of Algorithmics Assets from IBM
Davis Polk is advising SS&C Technologies Holdings, Inc. on its acquisition of assets of IBM’s Algorithmics business. The transaction is expected to close in the fourth quarter of 2019,…